AbstractFull TextImages/Data ReferencesRelated Articles Expand allCollapse all To the Editor: We have 2 questions for Dr Beyea, who described a patient with acute phosphate nephropathy after consumption of oral sodium phosphate solution (OSPS) for colonoscopy. Acute phosphate nephropathy following oral sodium phosphate soution to cleanse the bowel for colonoscopy. Their report belongs to a small group of recently published cases describing coincidence of acute renal failure after bowel cleansing with OSPS and renal heavy deposition of calcium phosphate concretions.First, the authors wrote that phosphate nephropathy differs from nephrocalcinosis by virtue of “distinct histopathologic findings.We question the accuracy of the distinction between nephrocalcinosis and phosphate nephropathy. Nephrocalcinosis refers to intrarenal deposits of calcium, regardless of whether these deposits occur in the form of phosphate or oxalate salts. In our view, phosphate nephropathy represents an acute nephrocalcinosis.Second, the authors wrote that the patient “has required management for anemia and secondary hyperparathyroidism,but they did not mention the time of follow-up of the chronic renal disease. Is there any possibility that the patient’s hyperparathyroidism was primary? Underlying subclinical primary hyperthyroidism might be a very appealing factor to explain the intriguing puzzle of why only very few patients develop this ominous complication among all the people using OSPS. Primary hyperparathyroidism has been described in one case may be undiagnosed when acute hyperphosphatemia lowers serum calcium levels, and offers the best conditions for nephrocalcinosis in the presence of an oral charge of phosphate, as it is demonstrated in experimental settings

Nephrocalcinosis in phosphate nephropathy following oral phosphate purgative: a role for underlying subclinical primary hyperparathyroidism?

STRATTA, Piero;QUAGLIA, Marco
2007-01-01

Abstract

AbstractFull TextImages/Data ReferencesRelated Articles Expand allCollapse all To the Editor: We have 2 questions for Dr Beyea, who described a patient with acute phosphate nephropathy after consumption of oral sodium phosphate solution (OSPS) for colonoscopy. Acute phosphate nephropathy following oral sodium phosphate soution to cleanse the bowel for colonoscopy. Their report belongs to a small group of recently published cases describing coincidence of acute renal failure after bowel cleansing with OSPS and renal heavy deposition of calcium phosphate concretions.First, the authors wrote that phosphate nephropathy differs from nephrocalcinosis by virtue of “distinct histopathologic findings.We question the accuracy of the distinction between nephrocalcinosis and phosphate nephropathy. Nephrocalcinosis refers to intrarenal deposits of calcium, regardless of whether these deposits occur in the form of phosphate or oxalate salts. In our view, phosphate nephropathy represents an acute nephrocalcinosis.Second, the authors wrote that the patient “has required management for anemia and secondary hyperparathyroidism,but they did not mention the time of follow-up of the chronic renal disease. Is there any possibility that the patient’s hyperparathyroidism was primary? Underlying subclinical primary hyperthyroidism might be a very appealing factor to explain the intriguing puzzle of why only very few patients develop this ominous complication among all the people using OSPS. Primary hyperparathyroidism has been described in one case may be undiagnosed when acute hyperphosphatemia lowers serum calcium levels, and offers the best conditions for nephrocalcinosis in the presence of an oral charge of phosphate, as it is demonstrated in experimental settings
File in questo prodotto:
File Dimensione Formato  
Phosphate Nephropathy.pdf

file disponibile solo agli amministratori

Tipologia: Documento in Post-print
Licenza: DRM non definito
Dimensione 40.79 kB
Formato Adobe PDF
40.79 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11579/31646
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact